Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Parris

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
American Journal of Public Health|June 1, 1996
Risk factors for self-reported uterine fibroids: a case-control studyA R Samadi, N C Lee, W D Flanders, et al.
International Journal of Molecular Sciences|May 2, 2020
In Utero Exposure to Bisphenol a Promotes Mammary Tumor Risk in MMTV-Erbb2 Transgenic Mice Through the Induction of ER-erbB2 CrosstalkZhikun Ma, Amanda B Parris, Erin W Howard, et al.
Oncotarget|September 27, 2017
Phenformin inhibits growth and epithelial-mesenchymal transition of ErbB2-overexpressing breast cancer cells through targeting the IGF1R pathwayZhiying Guo, Ming Zhao, Erin W Howard, et al.
American Journal of Public Health|October 1, 1987
Occupational risk of HIV, HBV and HSV-2 infections in health care personnel caring for AIDS patientsT L Kuhls, S Viker, N B Parris, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 8, 2017
Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic miceZhikun Ma, Amanda B Parris, Zhengzheng Xiao, et al.
Carcinogenesis|August 15, 2018
Caloric restriction inhibits mammary tumorigenesis in MMTV-ErbB2 transgenic mice through the suppression of ER and ErbB2 pathways and inhibition of epithelial cell stemness in premalignant mammary tissuesZhikun Ma, Amanda B Parris, Erin W Howard, et al.
Scientific Reports|September 14, 2017
FGFR inhibitor, AZD4547, impedes the stemness of mammary epithelial cells in the premalignant tissues of MMTV-ErbB2 transgenic miceQingxia Zhao, Amanda B Parris, Erin W Howard, et al.
Angewandte Chemie (International Ed. in English)|December 20, 2023
Selective 1,2-Hydroarylation(Alkenylation) of gem-Difluoroalkenes to Access (-CF<sub>2</sub> H) MotifsLeroy Qi Hao Lin, Ángel Rentería-Gómez, Robert T Martin, et al.
Oncology Reports|July 18, 2018
DMBA promotes ErbB2‑mediated carcinogenesis via ErbB2 and estrogen receptor pathway activation and genomic instabilityZhikun Ma, Young Mi Kim, Erin W Howard, et al.
Oncotarget|September 24, 2017
Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cellsMing Zhao, Erin W Howard, Amanda B Parris, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
American Journal of Public Health|June 1, 1996
Risk factors for self-reported uterine fibroids: a case-control studyA R Samadi, N C Lee, W D Flanders, et al.
International Journal of Molecular Sciences|May 2, 2020
In Utero Exposure to Bisphenol a Promotes Mammary Tumor Risk in MMTV-Erbb2 Transgenic Mice Through the Induction of ER-erbB2 CrosstalkZhikun Ma, Amanda B Parris, Erin W Howard, et al.
Oncotarget|September 27, 2017
Phenformin inhibits growth and epithelial-mesenchymal transition of ErbB2-overexpressing breast cancer cells through targeting the IGF1R pathwayZhiying Guo, Ming Zhao, Erin W Howard, et al.
American Journal of Public Health|October 1, 1987
Occupational risk of HIV, HBV and HSV-2 infections in health care personnel caring for AIDS patientsT L Kuhls, S Viker, N B Parris, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 8, 2017
Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic miceZhikun Ma, Amanda B Parris, Zhengzheng Xiao, et al.
Carcinogenesis|August 15, 2018
Caloric restriction inhibits mammary tumorigenesis in MMTV-ErbB2 transgenic mice through the suppression of ER and ErbB2 pathways and inhibition of epithelial cell stemness in premalignant mammary tissuesZhikun Ma, Amanda B Parris, Erin W Howard, et al.
Scientific Reports|September 14, 2017
FGFR inhibitor, AZD4547, impedes the stemness of mammary epithelial cells in the premalignant tissues of MMTV-ErbB2 transgenic miceQingxia Zhao, Amanda B Parris, Erin W Howard, et al.
Angewandte Chemie (International Ed. in English)|December 20, 2023
Selective 1,2-Hydroarylation(Alkenylation) of gem-Difluoroalkenes to Access (-CF<sub>2</sub> H) MotifsLeroy Qi Hao Lin, Ángel Rentería-Gómez, Robert T Martin, et al.
Oncology Reports|July 18, 2018
DMBA promotes ErbB2‑mediated carcinogenesis via ErbB2 and estrogen receptor pathway activation and genomic instabilityZhikun Ma, Young Mi Kim, Erin W Howard, et al.
Oncotarget|September 24, 2017
Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cellsMing Zhao, Erin W Howard, Amanda B Parris, et al.
Pageof 4